Drug-induced QT interval shortening: an emerging component in integrated assessment of cardiac safety of drugs.
Shah
Rashmi R
RR
Bjerregaard
Preben
P
Gussak
Ihor
I
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced; D010641:Phenotype; D013577:Syndrome; D014481:United States; D014486:United States Food and Drug Administration